Literature DB >> 5274344

Factors determining cell killing by chemotherapeutic agents in vivo. I. Cyclophosphamide.

L M van Putten, P Lelieveld.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5274344     DOI: 10.1016/0014-2964(70)90096-4

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0014-2964            Impact factor:   9.162


× No keyword cloud information.
  13 in total

1.  The effect of microsomal enzyme inhibition on the immunosuppressive and toxic effects of cyclophosphamide.

Authors:  M C Berenbaum; W A Cope; J A Double
Journal:  Clin Exp Immunol       Date:  1973-06       Impact factor: 4.330

Review 2.  Selective uptake and retention of anticancer agents by sensitive cells.

Authors:  D L Hill; J A Montgomery
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

Review 3.  Therapeutic drug monitoring in oncology. Problems and potential in antineoplastic therapy.

Authors:  M J Moore; C Erlichman
Journal:  Clin Pharmacokinet       Date:  1987-10       Impact factor: 6.447

4.  Effects of cytotoxic immunosuppressants on tuberculin-sensitive lymphocytes in guinea pigs.

Authors:  A Winkelstein
Journal:  J Clin Invest       Date:  1975-12       Impact factor: 14.808

5.  Drug-induced immunological unresponsiveness: selective inhibition of T-cell 'helper function' by cyclophosphamide in mice pretreated with phytohaemagglutinin.

Authors:  G Schwarze
Journal:  Clin Exp Immunol       Date:  1977-01       Impact factor: 4.330

6.  Cyclophosphamide treatment antagonizes the in vitro development of Mycobacterium lepraemurium-induced suppressor cell precursors.

Authors:  D Gosselin; R Turcotte; S Lemieux
Journal:  Clin Exp Immunol       Date:  1992-08       Impact factor: 4.330

7.  Cyclophosphamide-like cellular immunostimulation induced by 6-thioguanine (Lanvis).

Authors:  H Van Dijk; G A Voermans
Journal:  Immunology       Date:  1978-06       Impact factor: 7.397

8.  Long-lasting enhancement of the delayed-type hypersensitivity response to heterologous erythrocytes in mice after a single injection of cyclophosphamide.

Authors:  D H Bovbjerg; R Ader; N Cohen
Journal:  Clin Exp Immunol       Date:  1986-12       Impact factor: 4.330

Review 9.  The use of ferrokinetics in the study of experimental anemia.

Authors:  E W Lee; J J Kocsis; R Snyder
Journal:  Environ Health Perspect       Date:  1981-06       Impact factor: 9.031

10.  The effect of cyclophosphamide on the growth and cellular kinetics of a transplantable rat fibrosarcoma.

Authors:  S Peel; D M Cowen
Journal:  Br J Cancer       Date:  1972-08       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.